Maverick Medical AI, a New York-based commercial-stage company that provides a platform that understands unstructured patient reports and autonomously codes them for reimbursement claims, raised $5 million in Seed funding.
The round was led by Lionbird and Firstime Ventures, with participation from Ariel Maislos, Ofir Shalvi, Ehud Weinstein, and Eli Ben Dor. The company intends to use the funds to expand operations and its business reach.
Company: Maverick Medical AI Ltd.
Round: Seed Round
Funding Month: March 2022
Lead Investors: Lionbird and Firstime Ventures
Additional Investors: Ariel Maislos, Ofir Shalvi, Ehud Weinstein and Eli Ben Dor
Company Website: https://www.maverick-med.com/
Software Category: Medical Coding Platform
About the Company: Founded in 2018 by senior executives in the digital health industry, Yossi Shahak and Michael Brozino, Maverick Medical AI provides healthcare providers across all care settings with a SaaS platform, called mCoder™, which uses advanced artificial intelligence and deep learning technology for enabling generation of Synthetic data. The platform has been validated and used by several U.S. healthcare providers in the $16.4 billion U.S. medical coding market (2020 figures). The company has locations in Israel and the US.